Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8148978 | 1.00 | SRD5A2 (1.00) | SRD5A2SRD5A1 | |
| SCHEMBL10704713 | 1.00 | SRD5A2 (1.00) | SRD5A2SRD5A1 | |
| SCHEMBL8158161 | 0.90 | SRD5A2 (0.81) | SRD5A2SRD5A1 | |
| SCHEMBL8158159 | 0.90 | SRD5A2 (0.81) | SRD5A2SRD5A1 | |
| SCHEMBL9111609 | 0.88 | SRD5A2 (0.78) | SRD5A2SRD5A1 | |
| SCHEMBL8802570 | 0.88 | SRD5A2 (0.77) | SRD5A2SRD5A1 | |
| SCHEMBL8803249 | 0.88 | SRD5A2 (0.77) | SRD5A2SRD5A1 | |
| SCHEMBL8802666 | 0.86 | SRD5A2 (0.75) | SRD5A2SRD5A1 | |
| SCHEMBL8149717 | 0.86 | SRD5A2 (0.75) | SRD5A2SRD5A1 | |
| SCHEMBL8149720 | 0.86 | SRD5A2 (0.75) | SRD5A2SRD5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0521080-B1 | SYNERGISTIC COMPOSITIONS | SMITHKLINE BEECHAM CORP (US) | 1996-12-11 | — | — | EP | claimed |
| EP-0684765-A4 | TREATING ALOPECIA BY ADMINISTERING 5-ALPHA-REDUCTASE INHIBITING COMPOUNDS. | SMITHKLINE BEECHAM CORP (US) | 1996-12-04 | — | — | EP | claimed |
| US-5516768-A | Uncompetitive inhibition of steroid and 5α-reductose | SMITHKLINE BEECHAM CORPORATION (US) | 1996-05-14 | — | — | US | claimed |
| EP-0684765-A1 | TREATING ALOPECIA BY ADMINISTERING 5-ALPHA-REDUCTASE INHIBITING COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-12-06 | — | — | EP | claimed |
| WO-1994017663-A1 | TREATING ALOPECIA BY ADMINISTERING 5-ALPHA-REDUCTASE INHIBITING COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-08-18 | — | — | WO | claimed |
| EP-0521080-A4 | SYNERGISTIC COMPOSITIONS | — | 1993-11-24 | — | — | EP | claimed |
| EP-0521080-A1 | SYNERGISTIC COMPOSITIONS. | SMITHKLINE BEECHAM CORP (US) | 1993-01-07 | — | — | EP | claimed |
| EP-0289327-B1 | STEROID 5-ALPHA-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1991-12-18 | — | — | EP | claimed |
| WO-1991013550-A1 | SYNERGISTIC COMPOSITIONS | SMITHKLINE BEECHAM CORPORATION (US) | 1991-09-19 | — | — | WO | claimed |
| US-5017568-A | Enzyme inhibitors, carboxylation | SMITHKLINE BEECHAM CORPORATION (US) | 1991-05-21 | — | — | US | claimed |
| EP-0289327-A2 | Steroid 5-alpha-reductase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1988-11-02 | — | — | EP | claimed |
| US-6046183-A | SYNERGISTIC MIXTURE OF FINASTERIDE AND DOXAZOSIN | MERCK & CO., INC. (US) | 2000-04-04 | — | — | US | disclosed |
| US-5994362-A | ADMINISTERING FINASTERIDE AND CASODEX | MERCK & CO., INC. (US) | 1999-11-30 | — | — | US | disclosed |
| US-5753641-A | SYNERGISTIC THERAPY COMPRISING FINASTERIDE AND TERAZOSIN DRUGS | MERCK & CO., INC. (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0521080-B1 | SYNERGISTIC COMPOSITIONS | SMITHKLINE BEECHAM CORP (US) | 1996-12-11 | — | — | EP | disclosed |
| EP-0289327-B1 | STEROID 5-ALPHA-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1991-12-18 | — | — | EP | disclosed |
| WO-1991013550-A1 | SYNERGISTIC COMPOSITIONS | SMITHKLINE BEECHAM CORPORATION (US) | 1991-09-19 | — | — | WO | disclosed |
| US-5017568-A | Enzyme inhibitors, carboxylation | SMITHKLINE BEECHAM CORPORATION (US) | 1991-05-21 | — | — | US | disclosed |
| US-4910226-A | Estrane compound | SMITHKLINE BECKMAN CORPORATION (US) | 1990-03-20 | — | — | US | disclosed |
| EP-0289327-A2 | Steroid 5-alpha-reductase inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1988-11-02 | — | — | EP | disclosed |